Shares of Quidel Corp. (NASDAQ:QDEL) fell 1.4% during trading on Thursday . The stock traded as low as $21.52 and last traded at $21.55, with a volume of 60,290 shares changing hands. The stock had previously closed at $21.86.

Several research firms have commented on QDEL. Zacks Investment Research raised Quidel Corp. from a “hold” rating to a “buy” rating and set a $26.00 price objective for the company in a research note on Friday, July 29th. Canaccord Genuity reaffirmed a “hold” rating and set a $22.00 price objective on shares of Quidel Corp. in a research note on Friday, July 29th. Raymond James Financial Inc. raised Quidel Corp. from a “market perform” rating to an “outperform” rating and set a $21.50 price objective for the company in a research note on Monday, June 13th. Finally, TheStreet downgraded Quidel Corp. from a “hold” rating to a “sell” rating in a research note on Friday, May 6th. One analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $21.58.

The stock’s market capitalization is $688.33 million. The firm’s 50-day moving average is $21.07 and its 200-day moving average is $17.93.

Quidel Corp. (NASDAQ:QDEL) last posted its quarterly earnings results on Wednesday, July 27th. The company reported ($0.11) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.25) by $0.14. The firm earned $39.10 million during the quarter, compared to analyst estimates of $37.98 million. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter last year, the business posted ($0.14) earnings per share. On average, analysts predict that Quidel Corp. will post ($0.14) earnings per share for the current fiscal year.

In other Quidel Corp. news, SVP John Tamerius sold 7,000 shares of Quidel Corp. stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $23.02, for a total value of $161,140.00. Following the completion of the transaction, the senior vice president now directly owns 18,540 shares in the company, valued at $426,790.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Robert Joseph Bujarski sold 22,057 shares of Quidel Corp. stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $22.58, for a total value of $498,047.06. Following the completion of the transaction, the senior vice president now owns 60,100 shares of the company’s stock, valued at $1,357,058. The disclosure for this sale can be found here.

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company’s diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.